Antiviral therapy is effective in patients with HCV and non-organ-specific autoantibodies
=========================================================================================

ST. LOUIS (MD Consult)---The presence of non-organ-specific autoantibodies (NOSAs) in patients with hepatitis C virus (HCV) infection does not interfere with the response to combined antiviral therapy, according to the February 15 *Clinical Infectious Diseases*.

Dr Paolo Muratori and colleagues of Alma Mater Studiorum---University of Bologna in Italy studied 143 treatment-naïve adults with HCV. All patients were treated with combined interferon and ribavirin.

Blood samples were obtained at baseline to measure levels of NOSAs, specifically antinuclear antibody antismooth muscle antibody and antiliver/kidney microsomal antibody type 1.

NOSAs were present in 37 patients (25%). The proportion of patients with a good long-term response (i.e. persistently normal transaminase levels and undetectable HCV RNA levels 6 months after the end of treatment) was similar in the NOSA-positive and NOSA-negative patients (48.6 and 56.6%, respectively).

However, among NOSA-positive patients, those with HCV genotype 1 (HCV-1) were significantly less likely to have a good long-term response than those with another HCV genotype (30 vs 93.3%).

Multivariate analyses indicated that the detection of HCV-1 and elevated serum γ-glutamyl transpeptidase levels were significant and negative predictors of treatment response.

Thus, NOSA positivity should not be a contraindication to combined antiviral therapy in patients with HCV infection. However, NOSA-positive patients with the HCV-1 genotype appear to be much less likely to have a good long-term response.

*Clin Infect Dis.* 2005;**40**:501--7.

Ciprofloxacin reduces polyoma BKV load in patients after allogeneic HSCT
========================================================================

ST LOUIS (MD Consult)---Polyoma BK virus (BKV) infection has been linked to hemorrhagic cystitis in patients undergoing hematopoietic stem cell transplantation (HSCT). Ciprofloxacin can suppress urinary BKV reactivation after HSCT and thus may prevent severe hemorrhagic cystitis in these patients, according to a new study.

Dr Anskar Y. H. Leung and colleagues of the University of Hong Kong discuss their findings in the February 15 *Clinical Infectious Diseases*.

The authors studied 68 patients undergoing allogeneic HSCT. Patients received prophylaxis with either ciprofloxacin or a cephalosporin beginning on day 7 before HSCT and continuing to day 50 after HSCT.

All but 3 patients (95.6%) had BKV viruria. On the basis of weekly urine samples, patients receiving ciprofloxacin had a significantly lower peak BKV load than patients receiving a cephalosporin (median, 3×10^5^  copies/mL vs 2.6×10^9^  copies/mL, respectively).

Also, significantly fewer patients taking ciprofloxacin experienced a ≥3-log increase in BKV load. All 8 of the patients who developed hemorrhagic cystitis had a ≥3-log increase in BKV load.

The strong association between BKV load and severe hemorrhagic cystitis seen here and in other studies suggests that ciprofloxacin may be useful for preventing hemorrhagic cystitis after HSCT.

*Clin Infect Dis.* 2005;**40**:528--37.

Volume expansion with albumin may improve survival in children with severe malaria
==================================================================================

ST LOUIS (MD Consult)---Many children with severe falciparum malaria have metabolic acidosis and hypovolemia. Volume resuscitation with albumin appears to improve survival in these patients, according to the February 15 *Clinical Infectious Diseases.*

Dr Kathryn Maitland and colleagues of the Kenya Medical Research Institute in Kilifi and other institutions studied 150 children with severe malaria and metabolic acidosis (base deficit, \>8 mmol/L). Patients were randomized to 1 of 3 groups.

The first 2 groups received fluid resuscitation with either 4.5% albumin (*n*=56; group 1) or normal saline (*n*=61; group 2). Group 3 consisted of 33 patients with a base deficit of \<15 mmol/L who received maintenance therapy only and served as controls.

The proportion of patients whose acidosis resolved by 8 h after treatment did not differ significantly among the groups.

However, the mortality rate was significantly lower among the patients who received albumin (2 patients \[3.6%\]) than among patients who received saline (11 patients \[18%\]).

Although these findings require confirmation, fluid resuscitation with albumin may dramatically improve survival in high-risk children with severe malaria and metabolic acidosis.

*Clin Infect Dis.* 2005;**40**:538--45.

CD4-cell-count-guided interruption of antiretroviral therapy can be successful
==============================================================================

ST LOUIS (MD Consult)---Continuous antiretroviral therapy in patients with human immunodeficiency virus type 1 (HIV) infection is plagued by suboptimal compliance and multiple toxicities. Scheduled interruptions of antiretroviral therapy based on the CD4 cell count are as effective as continuous antiretroviral therapy, according to a new study, and these may reduce treatment-related toxicity and costs.

Dr Peter G. Cardiello and colleagues of the HIV Netherlands Australia Thailand Research Collaborative in Bangkok and other institutions discuss their findings in the February 15 *Clinical Infectious Diseases.*

The authors studied 74 patients with HIV infection who had been treated with 2 nucleoside reverse-transcriptase inhibitors (NRTIs) for 1 year followed by highly active antiretroviral therapy containing a protease inhibitor for 3 years. All had a CD4 cell count of ≥350 cells/μL and a plasma viral load of \<50 copies/mL at baseline.

Patients were randomized to receive either continuous antiretroviral therapy, CD4-cell-count-guided therapy, or week-on/week-off (WOWO) therapy.

In the second group, patients whose CD4 cell count was above a certain threshold (based on baseline values) stopped taking therapy and restarted therapy when their CD4 cell count increased above this threshold.

After 48 weeks of treatment, all patients were alive, and only 1 patient (in the WOWO group) had an AIDS-defining illness.

The proportion of patients with a CD4 cell count of ≥350 cells/μL did not differ significantly among the 3 groups: 100% in the continuous therapy group, 87% in the CD4-cell-count-guided group, and 96% in the WOWO group.

However, patients in the scheduled interruption groups achieved this level of success with much less exposure to antiretrovirals: patients in the WOWO group used antiretrovirals during only 69.8% of weeks, and those in the CD4-cell-count-guided group used antiretrovirals during only 41.1% of weeks.

Despite the high CD4 cell counts in the WOWO group, almost one third of these patients had virologic failure (i.e. HIV RNA level of \>50 copies/mL). The authors suspect this failure rate may be related to drug resistance as a result of previous dual-NRTI therapy. These findings suggest that CD4-cell-count-guided interruptions deserve further study as a means to reduce antiviral exposure in patients with HIV.

*Clin Infect Dis.* 2005;**40**:594--600.

Demand for prophylaxis after bioterrorism-related anthrax cases, 2001
=====================================================================

Belongia EA, Kieke B, Lynfield R, Davis JP, Besser RE

Media reports suggested increased public demand for anthrax prophylaxis after the intentional anthrax cases in 2001, but the magnitude of anthrax-related prescribing in unaffected regions was not assessed. We surveyed a random sample of 400 primary care clinicians in Minnesota and Wisconsin to assess requests for and provision of anthrax-related antimicrobial agents. The survey was returned by 239 (60%) of clinicians, including 210 in outpatient practice. Fifty-eight (28%) of those in outpatient practice received requests for anthrax-related antimicrobial agents, and 9 (4%) dispensed them. Outpatient fluoroquinolone use in both states was also analysed with regression models to compare predicted and actual use in October and November 2001. Fluoroquinolone use as a proportion of total antimicrobial use was not elevated, and anthrax concerns accounted for an estimated 0.3% of all fluoroquinolone prescriptions. Most physicians in Minnesota and Wisconsin managed anthrax-related requests without dispensing antimicrobial agents.

*Emerg Infect Dis* \[serial on the Internet\] 2005 Jan \[cited 13 January 2005\]. Available from: <http://www.cdc.gov/ncidod/eid/vol11no01/04-0272.htm>.

*Mycobacterium haemophilum* and lymphadenitis in children
=========================================================

Bruijnesteijn van Coppenraet LES, Kuijper EJ, Lindeboom JA, Prins JM, Claas ECJ

Infections associated with *Mycobacterium haemophilum* are underdiagnosed because specific culture methods required for its recovery are not applied routinely. Using polymerase chain reaction (PCR) technology on fine needle aspirates and biopsied specimens from 89 children with cervicofacial lymphadenitis, we assessed the importance of *M. haemophilum*. Application of a Mycobacterium genus-specific real-time PCR in combination with amplicon sequencing and a *M. haemophilum*-specific PCR resulted in the recognition of *M. haemophilum* as the causative agent in 16 (18%) children with cervicofacial lymphadenitis. *M. avium* was the most frequently found species (56%), and *M. haemophilum* was the second most commonly recognized pathogen. Real-time PCR results were superior to culture because only 9 (56%) of the 16 diagnosed *M. haemophilum* infections were positive by culture.

*Emerg Infect Dis* \[serial on the Internet\] 2005 Jan \[cited 13 January 2005\]. Available from: <http://www.cdc.gov/ncidod/eid/vol11no01/04-0589.htm>.

Invasive group A streptococcal infections, manifestations and their predictors, Montreal, 1995--2001
====================================================================================================

Hollm-Delgado M-G, Allard R, Pilon PA

We identified 306 invasive group A streptococcal infections (IGASI) by passive population-based surveillance in Montreal, Canada, from 1995 to 2001. The average yearly reported incidence was 2.4 per 100 000 persons, with a 14% death rate. Among clinical manifestations, incidence of pneumonia increased from 0.06 per 100 000 in 1995 to 0.50 per 100 000 in 2000. Over a span of 7 years, the odds of developing pneumonia increased (odds ratio \[OR\]=1.21, 95% confidence interval \[CI\] 1.0--1.5), while they decreased for soft-tissue infections (OR=0.86, 95% CI 0.7--1.0). Serotypes M1 and M3 accounted for 30% of IGASI. However, neither serotype was significantly associated with specific clinical manifestations, which suggests that manifestation development among IGASI might be attributable to host or environmental factors rather than the pathogen. In our study, these factors included age, gender, underlying medical conditions, and living environment, yet none explained temporal changes in risk for pneumonia and soft-tissue infections.

*Emerg Infect Dis* \[serial on the Internet\] 2005 Jan \[cited 13 January 2005\]. Available from: <http://www.cdc.gov/ncidod/eid/vol11no01/03-0651.htm>.

Norovirus and foodborne disease, United States, 1991--2000
==========================================================

Widdowson M-A, Sulka A, Bulens SN, Beard RS, Chaves SS, Hammond R, et al.

Efforts to prevent foodborne illness target bacterial pathogens, yet noroviruses (NoV) are suspected to be the most common cause of gastroenteritis. New molecular assays allow for better estimation of the role of NoV in foodborne illness. We analysed 8271 foodborne outbreaks reported to the Centres for Disease Control and Prevention from 1991 to 2000 and additional data from 6 states. The proportion of NoV-confirmed outbreaks increased from 1% in 1991 to 12% in 2000. However, from 1998 to 2000, 76% of NoV outbreaks were reported by only 11 states. In 2000, an estimated 50% of foodborne outbreaks in 6 states were attributable to NoV. NoV outbreaks were larger than bacterial outbreaks (median persons affected: 25 versus 15), and 10% of affected persons sought medical care; 1% were hospitalized. More widespread use of molecular assays will permit better estimates of the role of NoV illness and help direct efforts to control foodborne illness.

*Emerg Infect Dis* \[serial on the Internet\] 2005 Jan \[cited 13 January 2005\]. Available from: <http://www.cdc.gov/ncidod/eid/vol11no01/04-0426.htm>.

Evaluation of an accelerated protocol for detection of extended-spectrum beta-lactamase-producing gram-negative bacilli from positive blood cultures
====================================================================================================================================================

Navon-Venezia S, Leavitt A, Ben-Ami R, Aharoni Y, Schwaber MJ, Schwartz D, Carmeli Y

We evaluated a protocol for the accelerated detection of extended-spectrum beta-lactamases (ESBLs) in gram-negative bloodstream pathogens. Two hundred eighty-three blood culture bottles were subjected to direct ESBL testing by inoculating samples directly from blood culture bottles onto agar plates containing cefotaxime and ceftazidime disks, with and without clavulanate. Standard ESBL testing in accordance with the NCCLS guidelines after subculturing on agar plates was performed in parallel. Results of the direct ESBL testing were reported 2.3 days sooner and were comparable to those of the standard NCCLS method with sensitivity, specificity, and positive and negative predictive values of 100, 98, 94, and 100%, respectively.

*J Clin Microbiol* 2005;**43**(1):439--41.

PMID: 15635009 \[PubMed---in process\]

Human cytomegalovirus UL144 gene polymorphisms in congenital infections
=======================================================================

Picone O, Costa JM, Chaix ML, Ville Y, Rouzioux C, Leruez-Ville M

The human cytomegalovirus (HCMV) UL144 gene is a tumor necrosis factor-like receptor with the potential to affect HCMV virulence. HCMV strains display genetic variability in the UL144 region, and the analysis of a potential link between UL144 gene polymorphisms and disease severity has scarcely been studied. However, a correlation between the UL144 genotype and congenital-disease outcome has been reported in one previous study, with the observation that all asymptomatic infants had a single UL144 genotype. In order to confirm or refute this finding, we determined the UL144 polymorphisms of HCMV strains recovered from the amniotic fluids of 38 infected fetuses and compared them to HCMV strains obtained from 30 viremic adult controls. The UL144 sequences were distributed among five genotypes (A, B, C, AC, and AB), as previously described. We observed similar percentages of the three major genotypes A (37%), B (33%), and C (27%) in our population. The UL144 genotype distributions were similar among the group of infected adults and the group of infected fetuses and among symptomatic and asymptomatic fetuses (*P*\<0.05). In our series, all five UL144 genotypes could be vertically transmitted from mothers to fetuses, and all could cause symptomatic congenital infection. We concluded that determination of UL144 polymorphisms in cases of congenital infection is not relevant, since it is unlikely to help predict the outcome of the infection.

*J Clin Microbiol* 2005;**43**(1):25--9.
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Methicillin-resistant *Staphylococcus caprae* in a neonatal intensive care unit
===============================================================================

Ross TL, Fuss EP, Harrington SM, Cai M, Perl TM, Merz WG

*Staphylococcus caprae*, a hemolytic coagulase-negative staphylococcus that is infrequently associated with humans, was initially detected in specimens from six infants in our neonatal intensive care unit due to phenotypic characteristics common to methicillin-resistant *Staphylococcus aureus*. These isolates were subsequently identified as *S. caprae* by the Automated RiboPrinter microbial characterization system. This prompted an 8-month retrospective investigation in our neonatal intensive care unit. *S. caprae* was the cause of 6 of 18 episodes of coagulase-negative staphylococcal bacteraemia, was the most common coagulase-negative staphylococcus recovered from the nares of 6 of 32 infants surveyed in a methicillin-resistant *S. aureus* surveillance program, and was isolated from 1 of 37 health care providers\' hands. Of 13 neonatal intensive care unit isolates tested, all were methicillin resistant and positive for the mecA gene. All 21 isolates were found to be a single strain by Automated RiboPrinter and pulsed-field gel electrophoresis with ApaI or SmaI digestion; ApaI was more discriminating in analyzing epidemiologically unrelated strains than Automated RiboPrinter or electrophoresis with SmaI. These findings extend the importance of *S. caprae*, emphasize its similarities to methicillin-resistant *S. aureus*, and demonstrate its ability to persist in an intensive care unit setting.

*J Clin Microbiol* 2005;**43**(1):363--7.
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Emerging incidence of *Enterococcus faecium* among hospital isolates (1993 to 2002)
===================================================================================

Treitmna AN, Yarnold PR, Warren J, Noskin GA

Historically, most clinical microbiology laboratories report that 80 to 90% of enterococci are *Enterococcus faecalis*, whereas *E. faecium* accounts for 5 to 10% of isolates. At our medical centre from 1993 to 2002, we evaluated the percentages of *E. faecium* among all enterococcal isolates and the percentages of *E. faecium* isolates that were vancomycin resistant. Over this 10-year period, the percentage of enterococci that were identified as *E. faecium* increased from 12.7 to 22.2% (*P*\<0.001) and the proportion of *E. faecium* that was vancomycin resistant increased from 28.9 to 72.4% (*P*\<0.001). Both the percentage of *E. faecium* among the enterococci and the proportion of vancomycin-resistant *E. faecium* increased significantly over this 10-year period.

*J Clin Microbiol* 2005;**43**(1):462--3.
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Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study
===========================================================================================================

McClelland RS, Lavreys L, Katingima C, Overbaugh J, Chohan V, Mandaliya K, Ndinya-Achola J, Baeten JM

Background:

Sexually transmitted diseases (STDs) enhance human immunodeficiency virus (HIV)-1 susceptibility, but few studies have examined the reciprocal effect of HIV-1 on STD acquisition.

Methods:

Data from a prospective cohort study conducted among female sex workers in Mombasa, Kenya, between 1993 and 2003 were used to determine the effect of HIV-1 infection on STD susceptibility. The cohort included 1215 HIV-1-seronegative women who underwent monthly HIV-1 and STD screening, of whom 238 experienced seroconversion to HIV-1 during follow-up. Andersen-Gill proportional-hazards models were used to compare the incidence rates for genital-tract infections (syphilis, genital ulcer disease \[GUD\], *Neisseria gonorrhoeae* infection, *Chlamydia trachomatis* infection, *Trichomonas vaginalis* infection, vulvovaginal candidiasis, and bacterial vaginosis) in HIV-1-seropositive versus HIV-1-seronegative women, after controlling for sexual behavior and other potential confounding factors.

Results:

HIV-1 infection was associated with a significantly higher incidence of GUD (hazard ratio \[HR\], 2.8; 95% confidence interval \[CI\], 2.0--3.9), gonorrhea (HR, 1.6; 95% CI, 1.1--2.2), and vulvovaginal candidiasis (HR, 1.5; 95% CI, 1.3--1.8). The risks of GUD and vulvovaginal candidiasis increased with progressive levels of immunosuppression.

Conclusions:

The increased incidence of genital-tract infections among HIV-1-seropositive women could promote the spread of both HIV-1 and other STDs, particularly in areas where these conditions are highly prevalent.

*J Infect Dis* 2005;**191**(3):333--8.
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Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy
===========================================================================================================================

Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, Brumme CJ, Brumme ZL, Mo T, Alexander CS, Montaner JS

Study objective:

The objective of this study was to systematically characterize the incidence and determinants of antiretroviral resistance in the HOMER (Highly Active Antiretroviral Therapy \[HAART\] Observational Medical Evaluation and Research) cohort of 1191 human immunodeficiency virus-infected, antiretroviral-naive adults initiating HAART in British Columbia, Canada.

Methods:

All plasma samples with plasma virus loads (pVLs)\>1000 copies/mL collected during the first 30 months of follow-up were genotyped for drug resistance. The primary outcome measure was time to the first detection of major drug-resistance mutation(s). Cox proportional hazard regression was used to identify factors significantly associated with the detection of drug-resistance mutations.

Results:

Drug-resistance mutations were detected in 298 subjects (25%). Factors significantly associated with detection of drug-resistance mutations included high baseline pVL (multivariate hazard ratio \[HR\], 1.59; *P*\<.001) and adherence (estimated using prescription-refill data and/or untimed plasma drug-concentration measurements). When compared with subjects with low (0% to \<20%) prescription-refill percentages, subjects at an elevated risk of harboring drug-resistance mutations were those with relatively high but imperfect prescription-refill percentages (80% to \<90%; multivariate HR, 4.15; *P*\<.001) and those with essentially perfect (≥95%) refill percentages but with 2 plasma drug concentrations below the steady-state trough concentration minus 1 standard deviation (multivariate HR, 4.57; *P*\<.001). Initial use of nonnucleoside reverse-transcriptase inhibitor-based HAART was significantly associated with multiclass drug resistance (multivariate HR, 1.84; *P*=.001).

Conclusions:

High baseline pVLs and substantial but imperfect levels of adherence were major predictors of antiretroviral resistance.

*J Infect Dis* 2005;**191**(3):339--47.
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Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy
=========================================================================================================================================

Ostrowski SR, Katzenstein TL, Thim PT, Pedersen BK, Gerstoft J, Ullum H

Background:

Immunological and virological consequences of low-level viremia in human immunodeficiency virus (HIV) type 1-infected patients receiving highly active antiretroviral therapy (HAART) remain to be determined.

Methods:

For 24 months, 101 HAART-treated, HIV-1-infected patients with HIV RNA levels ≤200 copies/mL were followed prospectively: HIV RNA level and CD4 and CD8 cell counts were investigated every 3 months, and proviral DNA and T cell subsets were investigated every 6 months.

Results:

During follow-up, 33 patients had HIV RNA levels ≤20 copies/mL at all visits (uVL patients), whereas 68 patients had HIV RNA levels \>20 copies/mL at ≥1 visit (dVL patients) (median increase, 81 copies/mL \[interquartile range, 37--480 copies/mL\]). dVL patients had higher concentrations of CD8 cells, activated and memory T-cells, and proviral DNA, compared with uVL patients (*P*\<.05). A higher HIV RNA level was independently associated with reduced CD4 gain (*P*\<.001). A higher HIV RNA level also was associated with increases in activated CD8(+)CD38(+) and CD8(+)HLA-DR(+) cells (*P*\<.05), and a higher level of activated CD8(+)CD38(+) cells was independently associated with reduced CD4 gain (*P*\<.05). A higher proviral DNA level was associated with increases in CD4(+)CD45RA(−)CD28(−) effector cells and reductions in naive CD4(+)CD45RA(+)CD62L(+) and CD8(+)CD45RA(+)CD62L(+) cells (*P*\<.05). Higher levels of activated CD4(+)HLA-DR(+) and early differentiated CD4(+)CD45RA(−)CD28(+) cells predicted increased risk of subsequent detectable viremia in patients with undetectable HIV RNA (*P*\<.05).

Conclusions:

These findings indicate that low-level viremia and proviral DNA are intimately associated with the immunological and virological equilibrium in patients receiving HAART.

*J Infect Dis* 2005;**191**(3):348--57.
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Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis
=========================================================================================================================================

Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C, Shears P, Smyth RL, Hart CA

The association between severe bronchiolitis and dual infection by human metapneumovirus (hMPV) and human respiratory syncytial virus (hRSV) was investigated in \<2-year-old infants with bronchiolitis who were admitted to the hospital during the 2001--2002 winter season. hMPV in nasopharyngeal aspirate and/or cells and fluid collected by nonbronchoscopic bronchoalveolar lavage was detected by reverse transcriptase-polymerase chain reaction (RT-PCR). hRSV was detected in nasopharyngeal aspirate and/or cells and fluid collected by nonbronchoscopic bronchoalveolar lavage by enzyme immunoassay, tissue culture, and RT-PCR. Dual infection with hMPV and hRSV confers a 10-fold increase in relative risk (RR) of admission to a pediatric intensive-care unit for mechanical ventilation (RR, 10.99 \[95% confidence interval, 5.0--24.12\]; *P*\<.001, by Fisher exact test). Dual infection by hMPV and hRSV is associated with severe bronchiolitis.

*J Infect Dis* 2005;**191**(3):382--6.
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Human disease from influenza A (H5N1), Thailand, 2004
=====================================================

Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, et al.

Influenza A (H5N1) is endemic in poultry across much of Southeast Asia, but limited information exists on the distinctive features of the few human cases. In Thailand, we instituted nationwide surveillance and tested respiratory specimens by polymerase chain reaction and viral isolation. From January 1 to March 31, 2004, we reviewed 610 reports and identified 12 confirmed and 21 suspected cases. All 12 confirmed case-patients resided in villages that experienced abnormal chicken deaths, 9 lived in households whose backyard chickens died, and 8 reported direct contact with dead chickens. Seven were children \<14 years of age. Fever preceded dyspnea by a median of 5 days, and lymphopenia significantly predicted acute respiratory distress syndrome development and death. Among hundreds of thousands of potential human cases of influenza A (H5N1) in Asia, a history of direct contact with sick poultry, young age, pneumonia and lymphopenia, and progression to acute respiratory distress syndrome should prompt specific laboratory testing for H5 influenza.

*Emerg Infect Dis* \[serial on the Internet\] 2005 Feb \[cited 14 February 2005\]. Available from: <http://www.cdc.gov/ncidod/eid/vol11no02/04-1061.htm>.

Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004
============================================================================

Thanh Liem NT, World Health Organization International Avian Influenza Investigation Team, Vietnam, Lim W

To establish whether human-to-human transmission of influenza A H5N1 occurred in the healthcare setting in Vietnam, we conducted a cross-sectional seroprevalence survey among hospital employees exposed to 4 confirmed and 1 probable H5N1 case-patients or their clinical specimens. Eighty-three (95.4%) of 87 eligible employees completed a questionnaire and provided a serum sample, which was tested for antibodies to influenza A H5N1. Ninety-five percent reported exposure to ≥1 H5N1 case-patients; 59 (72.0%) reported symptoms, and 2 (2.4%) fulfilled the definition for a possible H5N1 secondary case-patient. No study participants had detectable antibodies to influenza A H5N1. The data suggest that the H5N1 viruses responsible for human cases in Vietnam in January 2004 are not readily transmitted from person to person. However, influenza viruses are genetically variable, and transmissibility is difficult to predict. Therefore, persons providing care for H5N1 patients should continue to take measures to protect themselves.

*Emerg Infect Dis* \[serial on the Internet\] 2005 Feb \[cited 14 February 2005\]. Available from: <http://www.cdc.gov/ncidod/eid/vol11no02/04-1075.htm>.

Bacterial zoonoses and infective endocarditis, Algeria
======================================================

Benslimani A, Fenollar F, Lepidi H, Raoult D

Blood culture-negative endocarditis is common in Algeria. We describe the etiology of infective endocarditis in this country. Samples from 110 cases in 108 patients were collected in Algiers. Blood cultures were performed in Algeria. Serologic and molecular analysis of valves was performed in France. Infective endocarditis was classified as definite in 77 cases and possible in 33. Causative agents were detected by blood cultures in 48 cases. All 62 blood culture-negative endocarditis cases were tested by serologic or molecular methods or both. Of these, 34 tested negative and 28 had an etiologic agent identified. A total of 18 infective endocarditis cases were caused by zoonotic and arthropodborne bacteria, including *Bartonella quintana* (14 cases), *Brucella melitensis* (2 cases), and *Coxiella burnetii* (2 cases). Our data underline the high prevalence of infective endocarditis caused by *Bartonella quintana* in northern Africa and the role of serologic and molecular tools for the diagnosis of blood culture-negative endocarditis.

*Emerg Infect Dis* \[serial on the Internet\] 2005 Feb \[cited 14 February 2005\]. Available from: <http://www.cdc.gov/ncidod/eid/vol11no02/04-0668.htm>.

*Pneumocystis jirovecii* in general population
==============================================

Medrano FJ, Montes-Cano M, Conde M, de la Horra C, Respaldiza N, Gasch A, et al.

The possible presence of Pneumocystis among healthy adults was examined by detecting *Pneumocystis jirovecii*-specific DNA in prospectively obtained oropharyngeal wash samples from 50 persons without underlying lung disease or immunosuppression. Pneumocystis carriage, defined by detecting Pneumocystis DNA by nested polymerase chain reaction in 2 independent analyses plus successful mitochondrial large subunit ribosomal RNA typing by direct sequencing, was found in 20% of cases. All carriers were asymptomatic, anti-HIV negative, and had normal total lymphocyte and CD4^+^ cell counts. A second sample obtained in the 6-month follow-up was positive in 2 of 9 available carriers. Genotype analysis showed different polymorphisms; 85A/248C (40%) and 85C/248C (30%) were most frequently observed. This study provides the first evidence that *P. jirovecii* DNA can be frequently detected in the respiratory tract of immunocompetent adults, which agrees with the hypothesis that the general population could be a reservoir and source of this infection.

*Emerg Infect Dis* \[serial on the Internet\] 2005 Feb \[cited 14 February 2005\]. Available from: <http://www.cdc.gov/ncidod/eid/vol11no02/04-0487.htm>.

Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of *Chlamydia trachomatis* in women with genital infections
============================================================================================================================================================================

Marrazzo JM, Johnson RE, Green TA, Stamm WE, Schachter J, Bolan G, Hook EW 3rd, Jones RB, Martin DH, St Louis ME, Black CM

The performance of nucleic acid amplified tests (NAAT) for *Chlamydia trachomatis* at the cervix and in urine was examined in 3551 women, and the impacts of clinical findings (age, endocervical and urethral inflammation, menses, and gonococcal coinfection) were assessed. Ligase chain reaction (LCR) and first-generation uniplex PCR were studied relative to an unamplified DNA probe (PACE2) and to an expanded, independent diagnostic reference standard. Relative to the expanded standard, cervical or urine LCR was generally the most sensitive test in most subgroups. Increased detection by NAAT of cervical C. trachomatis over PACE2 was highest among women without mucopurulent endocervical discharge versus those with (relative increase in positivity with cervical LCR, 46%) and among women ≥20 years old versus younger women (relative increase in positivity with cervical LCR, 45%). The sensitivity of cervical PCR was highest when mucopurulent endocervical discharge was present (84%) and highest for cervical LCR when cervical gonococcal coinfection was detected (91%). Urethral inflammation was associated with higher sensitivities of urine LCR (86 compared to 70% when inflammation was absent) and PCR (82 compared to 62% when inflammation was absent). Menses had no effect on test performance. The effects of patient characteristics on test specificities were less pronounced and were closely related to observed sensitivities. These findings support expanded use of NAAT for screening and diagnosis of *C. trachomatis* in diverse clinical populations of women.

*J Clin Microbiol* 2005;**43**(2):577--84.
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Evaluation of a two-step approach for large-scale, prospective genotyping of *Mycobacterium tuberculosis* isolates in the United States
=======================================================================================================================================

Cowan LS, Diem L, Monson T, Wand P, Temporado D, Oemig TV, Crawford JT

Genotyping of *Mycobacterium tuberculosis* isolates is useful in tuberculosis control for confirming suspected transmission links, identifying unsuspected transmission, and detecting or confirming possible false-positive cultures. The value is greatly increased by reducing the turnaround time from positive culture to genotyping result and by increasing the proportion of cases for which results are available. Although IS6110 fingerprinting provides the highest discrimination, amplification-based methods allow rapid, high-throughput processing and yield digital results that can be readily analysed and thus are better suited for large-scale genotyping. *M. tuberculosis* isolates (*n*=259) representing 99% of culture-positive cases of tuberculosis diagnosed in Wisconsin in the years 2000 to 2003 were genotyped by using spoligotyping, mycobacterial interspersed repetitive unit (MIRU) typing, and IS6110 fingerprinting. Spoligotyping clustered 64.1% of the isolates, MIRU typing clustered 46.7% of the isolates, and IS6110 fingerprinting clustered 29.7% of the isolates. The combination of spoligotyping and MIRU typing yielded 184 unique isolates and 26 clusters containing 75 isolates (29.0%). The addition of IS6110 fingerprinting reduced the number of clustered isolates to 30 (11.6%) if an exact pattern match was required or to 44 (17.0%) if the definition of a matching IS6110 fingerprint was expanded to include patterns that differed by the addition of a single band. Regardless of the genotyping method chosen, the addition of a second or third method decreased clustering. Our results indicate that using spoligotyping and MIRU typing together provides adequate discrimination in most cases. IS6110 fingerprinting can then be used as a secondary typing method to type the clustered isolates when additional discrimination is needed.
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Rapid diagnosis of herpes simplex virus infection by a loop-mediated isothermal amplification method
====================================================================================================

Enomoto Y, Yoshikawa T, Ihira M, Akimoto S, Miyake F, Usui C, Suga S, Suzuki K, Kawana T, Nishiyama Y, Asano Y

Primers for herpes simplex virus type 1 (HSV 1)-specific loop-mediated isothermal amplification (LAMP) method amplified HSV-1 DNA, while HSV-2-specific primers amplified only HSV-2 DNA; no LAMP products were produced by reactions performed with other viral DNAs. The sensitivities of the HSV-1- and HSV-2-specific LAMP methods, determined by agarose gel electrophoresis, reached 500 and 1000 copies/tube, respectively. The turbidity assay, however, determined the sensitivity of the HSV-1- and HSV-2-specific LAMP methods to be 1000 and 10 000 copies/tube, respectively. After initial validation studies, 18 swab samples (in sterilized water) collected from patients with either gingivostomatitis or vesicular skin eruptions were examined. HSV-1 LAMP products were detected by agarose gel electrophoresis in the 10 samples that also demonstrated viral DNA detection by real-time PCR. Nine of these 10 samples exhibited HSV-1 LAMP products by turbidity assay. Furthermore, both the agarose gel electrophoresis and the turbidity assay directly detected HSV-1 LAMP products in 9 of the 10 swab samples collected in sterilized water. Next, we examined the reliability of HSV type-specific LAMP for the detection of viral DNA in clinical specimens (culture medium) collected from genital lesions. HSV-2 was isolated from all of the samples and visualized by either agarose gel electrophoresis or turbidity assay.
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Detection of severe acute respiratory syndrome coronavirus RNA in plasma during the course of infection
=======================================================================================================

Wang Wk, Fang CT, Chen HL, Yang CF, Chen YC, Chen ML, Chen SY, Yang JY, Lin JH, Yang PC, Chang SC

We examined severe acute respiratory syndrome-associated coronavirus (SARS-CoV) RNA in plasma of 32 patients (probable SARS cases) by a quantitative real-time reverse transcription-PCR assay and reported that the highest detection rate, 75%, was found between day 5 and day 7 of illness, followed by rates of 64, 50, and 38% found between day 8 and day 11, day 2 and day 4, and day 12 and day 16, respectively. Analysis of sequential SARS-CoV load in plasma from six cases revealed different patterns of viremia, with the peak between day 4 and day 8. Our findings of the high detection rate of SARS-CoV RNA in plasma before day 11, together with the relative convenience of collecting and handling plasma, suggest that plasma can be used for early diagnosis of SARS.
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